American Journal of Medical Case Reports
ISSN (Print): 2374-2151 ISSN (Online): 2374-216X Website: http://www.sciepub.com/journal/ajmcr Editor-in-chief: Samy, I. McFarlane
Open Access
Journal Browser
Go
American Journal of Medical Case Reports. 2020, 8(12), 522-527
DOI: 10.12691/ajmcr-8-12-25
Open AccessCase Study

Vulvar Squamous Cell Carcinoma in a Patient with AIDS: A Case Study

Parinaz Ayat1, Sara Sharif1, Kevin Hewitt2, Arkadij Grigorian2, Sarah A. Goldman1 and Isabel M. McFarlane1,

1Department of Internal Medicine, State University of New York, Downstate Medical Center, Brooklyn, N.Y., U.S.A-11203

2Department of Radiology, State University of New York, Downstate Medical Center, Brooklyn, N.Y., U.S.A-11203

Pub. Date: September 28, 2020

Cite this paper:
Parinaz Ayat, Sara Sharif, Kevin Hewitt, Arkadij Grigorian, Sarah A. Goldman and Isabel M. McFarlane. Vulvar Squamous Cell Carcinoma in a Patient with AIDS: A Case Study. American Journal of Medical Case Reports. 2020; 8(12):522-527. doi: 10.12691/ajmcr-8-12-25

Abstract

Vulvar cancer comprises 5% of gynecological cancers with squamous cell carcinoma (SCC) being found in 90% of the cases. Vulvar intraepithelial neoplasia is human papilloma virus (HPV)-driven and is the precursor lesion in nearly 40% of all cases of vulvar SCC. Pruritus is reported as the most common initial manifestation of vulvar SCC which may be of a long duration with pain, discharge, and bleeding been less frequently reported which contributes to the delayed initial presentation of the disease. So far, there are no recommended screening strategies for vulvar cancer and HPV vaccination may be the only effective way for prevention. We present a case of advanced vulvar cancer in an immunocompromised host. We will review pertinent topics for the clinicians on HPV infection prevention, clinical course, staging and the need for strong efforts on patient education.

Keywords:
vulvar cancer vulvar squamous cell carcinoma HIV AIDS HPV

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Christina Louise Rasmussen, Louise T. Thomsen, Gitte Lerche Aalborg and Susanne K. Kjaer. Gynecol Oncol., 2020 Apr 8; S0090-8258(20)30255-9.
 
[2]  American Cancer Society. Cancer Facts and Figures. Atlanta GA: American Cancer Society. 2015; Available at: https://www.cancer.org/research/cancer-factsstatistics/all-cancer- facts-figures/cancer-facts-figures-2015.html.
 
[3]  M. Del Pino, L. Rodriguez-Carunchio, J. Ordi Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma Histopathology, 62 (1) (2013), pp. 161-175.
 
[4]  Y. Ueda, et al. Two distinct pathways to development of squamous cell carcinoma of the vulva J. Skin Cancer, 2011 (2011), p. 951250.
 
[5]  I.A. van der Avoort, et al. Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways Int. J. Gynecol. Pathol., 25 (1) (2006), pp. 22-29.
 
[6]  L.N. Hoang, et al. Squamous precursor lesions of the vulva: current classification and diagnostic challenges Pathology, 48 (4) (2016), pp. 291-302.
 
[7]  Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.2018, 68, 394-424.
 
[8]  Clancy AA, Spaans JN, Weberpals JI. The forgotten woman's cancer: vulvar squamous cell carcinoma (VSCC) and a targeted approach to therapy. AnnOncol. 2016; 27(9):1696-1705.
 
[9]  Karimi-Zarchi, M.; Peighmbari, F.; Karimi, N.; Rohi, M.; Chiti, Z. A comparison of 3 ways of conventional pap smear, liquid-based cytology and colposcopy vs cervical biopsy for early diagnosis of premalignant lesions or cervical cancer in women with abnormal conventional Pap test. Int. J. Biomed. Sci. 2013, 9, 205-210.
 
[10]  Mario Preti, et al. Role of human papillomavirus infection in the etiology of vulvar cancer in Italian women. Infect Agent Cancer. 2020; 15: 20. Published online 2020 Apr 1.
 
[11]  Mette T. Faber, et al. Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva, Cancer Epidemiology, 02 June 2017.
 
[12]  Jennifer Muigai , et al. Potential Delay in the Diagnosis of Vulvar Cancer and Associated Risk Factors in Women Treated in German Gynecological Practices. Oncotarget. 2018 Jan 3; 9(9): 8725-8730. PMID: 29492231.
 
[13]  Rasmussen CL, et al. Incidence of vulvar high-grade precancerous lesions and cancer in Denmark before and after introduction of HPV vaccination. Gynecologic Oncology.
 
[14]  Woolderink J. M., de Bock G. H., de Hullu J. A., Davy M. J., van der Zee A. G. J., Mourits M. J. E. Patterns and frequency of recurrences of squamous cell carcinoma of the vulva. Gynecologic Oncology. 2006; 103(1): 293-299.
 
[15]  Peri M1, et al. A Case of Stage I Vulvar Squamous Cell Carcinoma with Early Relapse and Rapid Disease Progression. Case Rep Oncol Med. 2019 Jul 3; 2019: 1018492.
 
[16]  Jill I. Allbritton MD. Vulvar Neoplasms, Benign and Malignant, Obstetrics and Gynecology Clinics, 2017-09-01, Volume 44, Issue 3, Pages 339-352. PMID: 28778635.
 
[17]  Hoang L.N., Park K.J., Soslow R.A., et al: Squamous precursor lesions of the vulva: current classification and diagnostic challenges. Pathology 2016; 48: pp. 291-302.
 
[18]  S. van der Steen, et al. New FIGO staging system of vulvar cancer indeed provides a better reflection of prognosis. Gynecologic Oncology, 2010-12-01, Volume 119, Issue 3, Pages 520-525.
 
[19]  Kataoka M. Y., Sala E., Baldwin P., et al. The accuracy of magnetic resonance imaging in staging of vulvar cancer: a retrospective multi-center study. Gynecologic Oncology. 2010; 117(1): 82-87.
 
[20]  Oonk M. H. M., Planchamp F., Baldwin P., et al. European Society of Gynecological Oncology guidelines for the management of patients with vulvar Cancer. International Journal of Gynecological Cancer. 2017; 27(4): 832-837.
 
[21]  Mukai Y1, et al. In Vivo. 2020 Jan-Feb; 34(1): 307-313.
 
[22]  J Kalter, et al. Effects and Moderators of Psychosocial Interventions on Quality of Life, and Emotional and Social Function in Patients with Cancer: An Individual Patient Data Meta-Analysis of 22 RCTs. Psychooncology. 2018 Apr; 27(4): 1150-1161. PMID: 29361206.
 
[23]  Sitarz K, et al. PV Infection Significantly Accelerates Glycogen Metabolism in Cervical Cells with Large Nuclei: Raman Microscopic Study with Subcellular Resolution. J. Mol. Sci. 2020, 21(8), 2667.
 
[24]  Faber M.T. et al. Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva, Cancer Epidemiology, 02 June 2017, 02 June 2017.
 
[25]  Center for Disease Control and prevention, VPH vaccine recommendation, Vaccine recommendation, available at: https://www.cdc.gov/vaccines/vpd/hpv/hcp/recommendations.html.
 
[26]  Fokom Domgue J., et al. Beliefs About HPV Vaccine’s Success at Cervical Cancer Prevention Among Adult US Women. JNCI Can Spectr. 2019 Dec; 3(4): pkz064. Published online 2019 Aug 27.
 
[27]  Fatima Ouasmanim, et al. Determinants of Patient Delay in Seeking Diagnosis and Treatment Among Moroccan Women with Cervical Cancer. Obstet Gynecol Int. 2016; 2016: 4840762. PMID: 27882055.